Thus, we revealed that HC0074027 modulates NSCLC chemoresistance via the miR-379-5p/IGF1 pathway, implying that our work highlighted a new underlying mechanism of NSCLC chemoresistance, which could be targeted to improve chemotherapy against NSCLC. The gene discussed is IGF1; the disease is non-small cell lung carcinoma.